Scientists from three academic centres want to develop an innovative cell therapy that will allow to treat congenital immunodeficiency disorder called neutropenia. Due to neutropenia, approx. 3,000 children a year are unvaccinated in Poland. Effective diagnostics could change this.
Co-creator of the "cancer vaccine" Dr. Jacek Jemielity together with chemists and biochemists from his team and Polish immunologists founded ExploRNA Therapeutics, a spin-off of the University of Warsaw. The company aims to bring inventions of Polish RNA modification experts to the higher technological level.